Climb Bio, Inc. CLYM Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Climb Bio, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Climb Bio, Inc.'s total equity?
- Climb Bio, Inc. (CLYM) reported total equity of $148.09M in Q1 2026.
- How has Climb Bio, Inc.'s total equity changed year-over-year?
- Climb Bio, Inc.'s total equity decreased by 23.4% year-over-year, from $193.39M to $148.09M.
- What is the long-term trend for Climb Bio, Inc.'s total equity?
- Over 5 years (2020 to 2025), Climb Bio, Inc.'s total equity has grown at a 45.1% compound annual growth rate (CAGR), from -$24.98M to $160.48M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.